Posts

Showing posts with the label rheumatoid arthritis immunology

ACR Set to Issue Updated Treatment Guidelines - Rheumatology Network

ACR Set to Issue Updated Treatment Guidelines    Rheumatology Network

News briefing: Gilead submits filgotinib to European regulators for UC; GW Pharmaceuticals launches PhIII trial for MS candidate made with cannabis extracts - Endpoints News

News briefing: Gilead submits filgotinib to European regulators for UC; GW Pharmaceuticals launches PhIII trial for MS candidate made with cannabis extracts    Endpoints News

The global autoimmune disease diagnostics market is projected to generate a revenue of $10012.9 million by 2030, and is predicted to progress at an 8.5% CAGR during the time period 2020-2030 - Stockhouse

The global autoimmune disease diagnostics market is projected to generate a revenue of $10012.9 million by 2030, and is predicted to progress at an 8.5% CAGR during the time period 2020-2030    Stockhouse

Cancer treatment could be replicated for COVID-19 - Mirage News

Cancer treatment could be replicated for COVID-19    Mirage News

COVID-19 Can Make Patients' Immune Systems Attack Their Own Bodies, Study Shows - ScienceAlert

COVID-19 Can Make Patients' Immune Systems Attack Their Own Bodies, Study Shows    ScienceAlert

Some COVID-19 Patients Have Antibodies That Attack The Body Like Autoimmune Diseases - Yahoo Lifestyle

Some COVID-19 Patients Have Antibodies That Attack The Body Like Autoimmune Diseases    Yahoo Lifestyle

Pfizer gets FDA nod for Xeljanz to treat juvenile idiopathic arthritis - Pharmaceutical Business Review

Pfizer gets FDA nod for Xeljanz to treat juvenile idiopathic arthritis    Pharmaceutical Business Review

U.S. FDA Approves Pfizer's XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis - Argus Press

U.S. FDA Approves Pfizer's XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis    Argus Press

Holistic immunology: Supporting patients at every stage of their journey - - pharmaphorum

Holistic immunology: Supporting patients at every stage of their journey -    pharmaphorum

Global immunology market size was valued at USD 77365.4 Million in 2018 and is projected to reach USD 143833.2 Million by 2026, exhibiting a CAGR of 8.1% in the forecast period. - Owned

Global immunology market size was valued at USD 77365.4 Million in 2018 and is projected to reach USD 143833.2 Million by 2026, exhibiting a CAGR of 8.1% in the forecast period.    Owned

Ulcerative Colitis Immunology Drugs Market Booming Demand Leading To Exponential CAGR Growth By 2026 | Industry Growth Insights - The Daily Chronicle

Ulcerative Colitis Immunology Drugs Market Booming Demand Leading To Exponential CAGR Growth By 2026 | Industry Growth Insights    The Daily Chronicle

Global immunology market size was valued at USD 77365.4 Million in 2018 and is projected to reach USD 143833.2 Million by 2026, exhibiting a CAGR of 8.1% in the forecast period. - Owned

Global immunology market size was valued at USD 77365.4 Million in 2018 and is projected to reach USD 143833.2 Million by 2026, exhibiting a CAGR of 8.1% in the forecast period.    Owned

COVID-19: Strict adherence to social isolation rules may mask the risk in RMD patients - medwireNews

COVID-19: Strict adherence to social isolation rules may mask the risk in RMD patients    medwireNews

Renowned Florida Rheumatologist Dr. Guillermo Valenzuela Expands Center of Excellence by Adding Dr. Christine Savage & Dr. Yesenia Santiago-Casas - PRNewswire

Renowned Florida Rheumatologist Dr. Guillermo Valenzuela Expands Center of Excellence by Adding Dr. Christine Savage & Dr. Yesenia Santiago-Casas    PRNewswire

Global immunology market size was valued at USD 77365.4 Million in 2018 and is projected to reach USD 143833.2 Million by 2026, exhibiting a CAGR of 8.1% in the forecast period. - Owned

Global immunology market size was valued at USD 77365.4 Million in 2018 and is projected to reach USD 143833.2 Million by 2026, exhibiting a CAGR of 8.1% in the forecast period.    Owned

Renowned Florida Rheumatologist Dr. Guillermo Valenzuela Expands Center of Excellence by Adding Dr. Christine Savage & Dr. Yesenia Santiago-Casas - PRNewswire

Renowned Florida Rheumatologist Dr. Guillermo Valenzuela Expands Center of Excellence by Adding Dr. Christine Savage & Dr. Yesenia Santiago-Casas    PRNewswire

Renowned Florida Rheumatologist Dr. Guillermo Valenzuela Expands Center of Excellence by Adding Dr. Christine Savage & Dr. Yesenia Santiago-Casas - PRNewswire

Renowned Florida Rheumatologist Dr. Guillermo Valenzuela Expands Center of Excellence by Adding Dr. Christine Savage & Dr. Yesenia Santiago-Casas    PRNewswire

Magenta nabs AbbVie alum as new CSO, while COO steps down - FierceBiotech

Magenta nabs AbbVie alum as new CSO, while COO steps down    FierceBiotech

Top pulmonology news in August: COVID-19 and air quality, vitamin D for asthma and more - Healio

Top pulmonology news in August: COVID-19 and air quality, vitamin D for asthma and more    Healio

Top pulmonology news in August: COVID-19 and air quality, vitamin D for asthma and more - Healio

Top pulmonology news in August: COVID-19 and air quality, vitamin D for asthma and more    Healio